SLC6A3 and schizophrenia: In light of the established various regulatory mechanisms across brain regions (Howes et al., 2024; Morón et al., 2002; Weinstein et al., 2017), our findings support the hypothesis that the availability of dopaminergic precursors does not primarily regulate striatal DAT availability in schizophrenia.